A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19

NCT05616728 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
231
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Enanta Pharmaceuticals, Inc